The Valley Desk

ArticleAdvances in therapyPublished

Assessment of the Value of Nivolumab Plus Ipilimumab for Treating Microsatellite Instability-High/Mismatch Repair Deficiency Metastatic Colorectal Cancer: Indirect Treatment Comparison and Cost-Effectiveness Analysis

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Advances in therapy
Published
Subject terms
Economic evaluation; Metastatic Colorectal Cancer; Indirect Treatment Comparison; Combination Immunotherapy; Microsatellite Instability-high; Nivolumab Plus Ipilimumab
PubMed ID
42709325
Added to directory
Source checked

Report a correction or request removal